Comex Reports Guinea-Bissau 30 - pharmaceutical products 3002 - human or animal blood

Deploy a report





Chart - Guinea-Bissau - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Guinea-Bissau - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Guinea-Bissau - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
Belgium 866.582 3.884.018 4.272.520 1.657.247 1.251.045
South Korea 51.000 111.000 152.000 6.000 60.000
Netherlands 77.374 97.453 136.661
Denmark 54.801 122.526 86.635 23.961
Japan 20.081 203.467 11.936 4.637 13.286
Brazil 20.864 141.568
Russia 61.595 84.390
France 21.156 73.292 1.870 1.393 31.084
Germany 20.770 31.847
Sweden 42.611
Others 17.956 8.094 23 16
Total 1,213,156 4,507,556 4,556,832 1,811,570 1,633,644

Chart - Guinea-Bissau - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Guinea-Bissau - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Guinea-Bissau - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
 04 - 2025 05 - 2025 06 - 2025
Japan 20.352
Belgium 5.789
South Korea 4.000
Total 20,352 4,000 5,789

Chart - Guinea-Bissau - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Guinea-Bissau - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Guinea-Bissau - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Import Countries
 2023 2024
Netherlands 5.142
Belgium 660
France 44
Total 5,142 704

Chart - Guinea-Bissau - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Guinea-Bissau - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Guinea-Bissau - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

No Data Available

Chart - Guinea-Bissau - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Guinea-Bissau - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Guinea-Bissau - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
Importaciones
Belgium 866.582 3.884.018 4.272.520 1.657.247 1.251.045
South Korea 51.000 111.000 152.000 6.000 60.000
Netherlands 77.374 97.453 136.661
Denmark 54.801 122.526 86.635 23.961
Japan 20.081 203.467 11.936 4.637 13.286
Brazil 20.864 141.568
Russia 61.595 84.390
France 21.156 73.292 1.870 1.393 31.084
Germany 20.770 31.847
Sweden 42.611
Others 17.956 8.094 23 16
Total 1,213,156 4,507,556 4,556,832 1,811,570 1,633,644

Date
Import Countries
 2023 2024
Exportaciones
Netherlands 5.142
Belgium 660
France 44
Total 5,142 704

Chart - Guinea-Bissau - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Guinea-Bissau - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Guinea-Bissau - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
 04 - 2025 05 - 2025 06 - 2025
Importaciones
Japan 20.352
Belgium 5.789
South Korea 4.000
Total 20,352 4,000 5,789

Exportaciones
No Data Available